| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
|
Dezember 2019 - 44 Präparate |
|
L | | FI | | | Bortezomib liquid Spirig HC 3.5 mg/1.4 ml | | 398.70 | 474.10 | 10% | | Injektionslösung: Bortezomibum 3.5mg / 1.4ml | Spirig HealthCare AG | A / SL / SG | FB | | G |  |
| | FI | | | Voriconazole Accord 200mg | | 132.94 | 169.00 | 10% | | Lyophilisat: Voriconazolum 200 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
L | | FI | PI | | Rosuvastatin NOBEL 5 mg | 30 | 7.12 | 16.35 | 10% | | Filmtabletten: Rosuvastatinum 5 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Rosuvastatin NOBEL 5 mg | 105 | 24.93 | 45.00 | 10% | | Filmtabletten: Rosuvastatinum 5 mg | NOBEL Pharma Schweiz AG | ● B / SL / SG | FB | | G |  |
L | | FI | | | Rosuvastatin NOBEL 10 mg | 30 | 8.12 | 17.50 | 10% | | Filmtabletten: Rosuvastatinum 10 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G |  |
L | | FI | | | Rosuvastatin NOBEL 10 mg | 105 | 28.43 | 49.05 | 10% | | Filmtabletten: Rosuvastatinum 10 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G |  |
L | | FI | | | Rosuvastatin NOBEL 20 mg | 30 | 11.78 | 25.80 | 10% | | Filmtabletten: Rosuvastatinum 20 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G |  |
L | | FI | | | Rosuvastatin NOBEL 20 mg | 105 | 41.24 | 63.75 | 10% | | Filmtabletten: Rosuvastatinum 20 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Temozolomid Accord 5 mg | 5 | 11.72 | 25.75 | 10% | | Kapseln: Temozolomidum 5 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Temozolomid Accord 5 mg | 20 | 43.03 | 65.80 | 10% | | Kapseln: Temozolomidum 5 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Accord 20 mg | 5 | 46.89 | 70.25 | 10% | | Kapseln: Temozolomidum 20 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Accord 20 mg | 20 | 166.28 | 207.30 | 10% | | Kapseln: Temozolomidum 20 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Accord 100 mg | 5 | 199.58 | 245.50 | 10% | | Kapseln: Temozolomidum 100 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Accord 100 mg | 20 | 703.22 | 823.70 | 10% | | Kapseln: Temozolomidum 100 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Accord 140 mg | 5 | 328.26 | 393.25 | 10% | | Kapseln: Temozolomidum 140 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Accord 140 mg | 20 | 1156.64 | 1330.05 | 10% | | Kapseln: Temozolomidum 140 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Accord 180 mg | 5 | 357.79 | 427.15 | 10% | | Kapseln: Temozolomidum 180 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Accord 180 mg | 20 | 1431.17 | 1631.15 | 10% | | Kapseln: Temozolomidum 180 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Accord 250 mg | 5 | 499.20 | 589.50 | 10% | | Kapseln: Temozolomidum 250 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
L | | FI | PI | | Posaconazol Accord 100 mg | 24 | 561.21 | 660.65 | 10% | | Magensaftresistente Tabletten: Posaconazolum 100 mg | Accord Healthcare AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Posaconazol Accord 100 mg | 96 | 2244.86 | 2523.55 | 10% | | Magensaftresistente Tabletten: Posaconazolum 100 mg | Accord Healthcare AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | AJOVY 225 mg | 1.5 ml | 445.08 | 527.35 | 10% | | Injektionslösung in Fertigspritze: Fremanezumabum 225mg / 1.5ml | Teva Pharma AG | B / SL | FB | | G |  |
L | | FI | PI | | AJOVY 225 mg | 3 x 1.5 ml | 1332.62 | 1523.05 | 10% | | Injektionslösung in Fertigspritze: Fremanezumabum 225mg / 1.5ml | Teva Pharma AG | B / SL | FB | | G |  |
L | | FI | PI | | Orkambi 100 mg lumacaftor / 125 mg ivacaftor | 56 | 11355.11 | 11885.00 | 10% | | Granulat: 2 Wirkstoffe | Vertex Pharmaceuticals (CH) GmbH | A / SL | FB | | G |  |
L | | FI | | | Orkambi 150 mg lumacaftor / 188 mg ivacaftor | 56 | 11355.11 | 11885.00 | 10% | | Granulat: 2 Wirkstoffe | Vertex Pharmaceuticals (CH) GmbH | A / SL | FB | | G |  |
L | | FI | | | MVASI 100 mg/4 ml | | 257.57 | 312.10 | 10% | | Infusionskonzentrat: Bevacizumabum 100mg / 4ml | Amgen Switzerland AG | A / SL | FB | | G |  |
L | | FI | | | MVASI 400 mg/16 ml | | 962.84 | 1117.50 | 10% | | Infusionskonzentrat: Bevacizumabum 400mg / 16ml | Amgen Switzerland AG | A / SL | FB | | G |  |
| | FI | PI | | Delstrigo | 30 | 628.50 | 737.90 | 10% | | Filmtabletten: 3 Wirkstoffe | MSD Merck Sharp & Dohme AG | A / SL | FB | | G |  |
| | FI | PI | | Pifeltro | 30 | 436.06 | 517.00 | 10% | | Filmtabletten: Doravirinum 100 mg | MSD Merck Sharp & Dohme AG | A / SL | FB | | G |  |
L | | FI | PI | | Talzenna 0.25 mg | 30 | 1750.07 | 1980.90 | 10% | | Kapseln: Talazoparibum | Pfizer AG | A / SL | FB | | G |  |
L | | FI | | | Talzenna 1 mg | 30 | 5250.89 | 5628.15 | 10% | | Kapseln: Talazoparibum 1 mg | Pfizer AG | A / SL | FB | | G |  |
L | | FI | PI | | Copaxone Pen 40 mg/ml | 12 | 815.29 | 952.35 | 10% | | Injektionslösung im Fertigpen: Glatirameri Acetas 40 mg/ml | Teva Pharma AG | B / SL | FB | | G |  |
L | | FI | | | Tremfya 100 mg/1 ml | | 2248.53 | 2527.60 | 10% | | Injektionslösung in einem Fertigpen: Guselkumabum 100 mg/ml | Janssen-Cilag AG | B / SL | FB | | G |  |
| | FI | | | Bortezomib liquid Spirig HC 7 mg/2.8 ml | | PA | PA | k.A. | | Injektionslösung: Bortezomibum 7mg / 2.8ml | Spirig HealthCare AG | A | FB | | G |  |
| | FI | PI | CM | BETADINA, desinfizierende Wundsalbe 10 mg/g | 30 g | PA | PA | k.A. | | Salbe: Iodum 10 mg | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | D | FB | | G |  |
| | FI | PI | CM | BETADINA, desinfizierende Wundsalbe 10 mg/g | 100 g | PA | PA | k.A. | | Salbe: Iodum 10 mg | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | D | FB | | G |  |
| | FI | | | Rosuvastatin NOBEL 40 mg | 30 | PA | PA | k.A. | | Filmtabletten: Rosuvastatinum 40 mg | NOBEL Pharma Schweiz AG | B | FB | | G |  |
| | FI | | | Rosuvastatin NOBEL 40 mg | 105 | PA | PA | k.A. | | Filmtabletten: Rosuvastatinum 40 mg | NOBEL Pharma Schweiz AG | B | FB | | G |  |
| | FI | PI | | Copaxone Pen 40 mg/ml | 3 | PA | PA | k.A. | | Injektionslösung im Fertigpen: Glatirameri Acetas 40 mg/ml | Teva Pharma AG | B | FB | | G |  |
| | FI | | | Mylotarg 5 mg | | PA | PA | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Gemtuzumabum Ozogamicinum 5 mg | Pfizer AG | A | FB | | G |  |
| | | PI | A | Infludo neue Formel | 20 ml | PA | PA | k.A. | | Tropfen zum Einnehmen: 2 Wirkstoffe | Weleda AG | D | FB | | G |  |
| | | PI | A | Infludo neue Formel | 50 ml | PA | PA | k.A. | | Tropfen zum Einnehmen: 2 Wirkstoffe | Weleda AG | D | FB | | G |  |
| | FI | PI | CM | Betadina | 30 ml | PA | PA | k.A. | | desinfizierende Lösung: Iodum 11 mg/ml | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | D | FB | | G |  |
| | FI | PI | CM | Betadina | 120 ml | PA | PA | k.A. | | desinfizierende Lösung: Iodum 11 mg/ml | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | D | FB | | G |  |